Applied Therapeutics Stock Quote APLT - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

4.28

Bid

4.30

Ask

5.21

Volume

429,224

4.24 Day's Range 4.45

1.18 52 Week Range 9.39

Market Cap

454.255M

Previous Close

4.23

Open

4.33

Last Trade

4.28

Last Trade Time

Financial Volume

$ 1,871,239

VWAP

4.3596

Average Volume (3m)

1,891,294

Shares Outstanding

105,886,831

Dividend Yield

PE Ratio

-3.79

Earnings Per Share (EPS)

-1.13

Revenue

9.99M

Net Profit

-119.76M

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic expos... Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.appliedtherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Applied Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APLT. The last closing price for Applied Therapeutics was $4.23. Over the last year, Applied Therapeutics shares have traded in a share price range of $ 1.18 to $ 9.39.

Applied Therapeutics currently has 105,886,831 shares outstanding. The market capitalization of Applied Therapeutics is $454.25 million. Applied Therapeutics has a price to earnings ratio (PE ratio) of -3.79.

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against...

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against...

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.44	-9.32203389831	4.72	4.8887	4.165	1149086	4.36718891	CS
4	-1.72	-28.6666666667	6	6.7	4.165	964157	5.24568663	CS
12	1.18	38.064516129	3.1	9.39	2.585	1891294	5.62010358	CS
26	1.5	53.9568345324	2.78	9.39	1.79	1585573	4.31055997	CS
52	2.92	214.705882353	1.36	9.39	1.18	1101627	3.64870188	CS
156	-12.31	-74.2013261001	16.59	25.59	0.4995	542606	3.58733757	CS
260	-3.76	-46.7661691542	8.04	57.39	0.4995	383048	7.39124928	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.81M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.26M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.77M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.22M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.44M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.34M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.37M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.21M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.83M
TSLATesla Inc	$ 168.29 (-1.11%)	109.81M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.52M